BIONET Statistics
Total Valuation
BIONET has a market cap or net worth of TWD 4.87 billion. The enterprise value is 4.58 billion.
Market Cap | 4.87B |
Enterprise Value | 4.58B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
BIONET has 47.29 million shares outstanding. The number of shares has increased by 0.55% in one year.
Shares Outstanding | 47.29M |
Shares Change (YoY) | +0.55% |
Shares Change (QoQ) | -0.31% |
Owned by Insiders (%) | 6.80% |
Owned by Institutions (%) | 0.52% |
Float | 42.95M |
Valuation Ratios
The trailing PE ratio is 77.92.
PE Ratio | 77.92 |
Forward PE | n/a |
PS Ratio | 4.18 |
PB Ratio | 4.12 |
P/FCF Ratio | 59.92 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.65, with an EV/FCF ratio of 56.30.
EV / Earnings | 72.94 |
EV / Sales | 3.93 |
EV / EBITDA | 50.65 |
EV / EBIT | 80.24 |
EV / FCF | 56.30 |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 4.87.
Current Ratio | 4.02 |
Quick Ratio | 3.77 |
Debt / Equity | 4.87 |
Debt / EBITDA | 1.10 |
Debt / FCF | 1.23 |
Interest Coverage | 80.79 |
Financial Efficiency
Return on equity (ROE) is 3.86% and return on invested capital (ROIC) is 2.03%.
Return on Equity (ROE) | 3.86% |
Return on Assets (ROA) | 1.50% |
Return on Capital (ROIC) | 2.03% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.49 |
Inventory Turnover | 8.65 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.44% in the last 52 weeks. The beta is 0.74, so BIONET's price volatility has been lower than the market average.
Beta (5Y) | 0.74 |
52-Week Price Change | +61.44% |
50-Day Moving Average | 121.00 |
200-Day Moving Average | 80.36 |
Relative Strength Index (RSI) | 34.95 |
Average Volume (20 Days) | 940,566 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BIONET had revenue of TWD 1.16 billion and earned 62.74 million in profits. Earnings per share was 1.32.
Revenue | 1.16B |
Gross Profit | 639.75M |
Operating Income | 57.04M |
Pretax Income | 87.76M |
Net Income | 62.74M |
EBITDA | 81.36M |
EBIT | 57.04M |
Earnings Per Share (EPS) | 1.32 |
Balance Sheet
The company has 1.26 billion in cash and 99.69 million in debt, giving a net cash position of 1.16 billion or 24.50 per share.
Cash & Cash Equivalents | 1.26B |
Total Debt | 99.69M |
Net Cash | 1.16B |
Net Cash Per Share | 24.50 |
Equity (Book Value) | 2.05B |
Book Value Per Share | 25.03 |
Working Capital | 1.27B |
Cash Flow
In the last 12 months, operating cash flow was 145.43 million and capital expenditures -64.15 million, giving a free cash flow of 81.29 million.
Operating Cash Flow | 145.43M |
Capital Expenditures | -64.15M |
Free Cash Flow | 81.29M |
FCF Per Share | 1.72 |
Margins
Gross margin is 55.01%, with operating and profit margins of 4.90% and 5.39%.
Gross Margin | 55.01% |
Operating Margin | 4.90% |
Pretax Margin | 7.55% |
Profit Margin | 5.39% |
EBITDA Margin | 7.00% |
EBIT Margin | 4.90% |
FCF Margin | 6.99% |
Dividends & Yields
This stock pays an annual dividend of 0.71, which amounts to a dividend yield of 0.67%.
Dividend Per Share | 0.71 |
Dividend Yield | 0.67% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 3 |
Payout Ratio | 52.00% |
Buyback Yield | -0.55% |
Shareholder Yield | 0.12% |
Earnings Yield | 1.28% |
FCF Yield | 1.67% |
Stock Splits
The last stock split was on September 23, 2010. It was a forward split with a ratio of 1.020894072.
Last Split Date | Sep 23, 2010 |
Split Type | Forward |
Split Ratio | 1.020894072 |